A concern for ophthalmic antibiotic resistance in Bangladesh

Md Nasir Ahmed, Mohammed Rahmatullah, Rownak Jahan, Chowdhury Alfi Afroze
{"title":"A concern for ophthalmic antibiotic resistance in Bangladesh","authors":"Md Nasir Ahmed, Mohammed Rahmatullah, Rownak Jahan, Chowdhury Alfi Afroze","doi":"10.1002/puh2.121","DOIUrl":null,"url":null,"abstract":"In 2022, Bangladesh witnessed a sudden surge in conjunctivitis infections with some hospitals reporting three times the usual patient load with conjunctivitis [1]. According to media reports, conjunctivitis, characterized by red eyes, eye pain, and irritation, may have spiked in Bangladesh since July 2022 and reached its peak by September [2]. The outbreak of conjunctivitis has been reported mainly in Chattogram, Dhaka, Sylhet, Narayanganj and Faridpur regions [3]. Conjunctivitis in most cases is caused by viral infections. In the current outbreak, nearly half of these patients are infected with human adenovirus [1]. Bangladesh has noted an outbreak of conjunctivitis during the COVID-19 pandemic with eye-related manifestations such as red eye, itching, watering, vision loss, acute infection and inflammation [4, 6]. Earlier outbreaks of acute viral haemorrhagic conjunctivitis had also happened in 1981 caused by enterovirus 70 (EV 70) [7]. Viral infections and viral conjunctivitis do not need antibiotics unless there is an added bacterial infection. However, in the current outbreak, topical antibiotics such as Moxifloxacin, and Chloramphenicol are freely dispensed by pharmacy retailers without the prescription of health professionals [2]. In addition, there is also rampant use of Ciprofloxacin, Dexamethasone, and Natamycin for a viral eye infection [8]. These activities are a cause of concern in terms of antimicrobial stewardship and rising antimicrobial resistance of ocular pathogens such as Staphylococcus spp., coagulase-negative staphylococci, methicillin-resistant, and Haemophilus spp.) in recent decades has been a concern [9]. In 2017, a study of antibiotic susceptibility on bacteria collected from infected eyes in Bangladesh, Staphylococcus, Streptococcus, and Pseudomonas species were resistant to Gatifloxacin, Gentamicin, Tobramycin, Cloxacillin, Ciprofloxacin, Moxifloxacin, Cefixime, and Cephalexin [10]. An increase in ophthalmic antibiotic resistance may be a major problem when indicated in cataract surgery, corneal ulcers or bacterial eye infections. Raising public awareness regarding the judicious use of ophthalmic antibiotics is essential to avoid unprecedented ophthalmic epidemics and antimicrobial resistance burden. Regulations for self-medication, distribution, and selling antibiotics should include ophthalmic antibiotics. Bangladesh should initiate nationwide surveillance on antibiotic resistance in ocular microorganisms. Visualization; resources; writing – original draft; project administration: Md Nasir Ahmed. Conceptualization; writing – review and editing; supervision: Mohammed Rahmatullah. Validation; writing – review and editing: Rownak Jahan. Investigation: Chowdhury Alfi Afroze. We would like to thank the reviewers for their time and effort in reviewing the manuscript. The authors have declared no conflicts of interest. Data sharing is not applicable to this article as no new data were created or analysed in this study.","PeriodicalId":74613,"journal":{"name":"Public health challenges","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public health challenges","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/puh2.121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In 2022, Bangladesh witnessed a sudden surge in conjunctivitis infections with some hospitals reporting three times the usual patient load with conjunctivitis [1]. According to media reports, conjunctivitis, characterized by red eyes, eye pain, and irritation, may have spiked in Bangladesh since July 2022 and reached its peak by September [2]. The outbreak of conjunctivitis has been reported mainly in Chattogram, Dhaka, Sylhet, Narayanganj and Faridpur regions [3]. Conjunctivitis in most cases is caused by viral infections. In the current outbreak, nearly half of these patients are infected with human adenovirus [1]. Bangladesh has noted an outbreak of conjunctivitis during the COVID-19 pandemic with eye-related manifestations such as red eye, itching, watering, vision loss, acute infection and inflammation [4, 6]. Earlier outbreaks of acute viral haemorrhagic conjunctivitis had also happened in 1981 caused by enterovirus 70 (EV 70) [7]. Viral infections and viral conjunctivitis do not need antibiotics unless there is an added bacterial infection. However, in the current outbreak, topical antibiotics such as Moxifloxacin, and Chloramphenicol are freely dispensed by pharmacy retailers without the prescription of health professionals [2]. In addition, there is also rampant use of Ciprofloxacin, Dexamethasone, and Natamycin for a viral eye infection [8]. These activities are a cause of concern in terms of antimicrobial stewardship and rising antimicrobial resistance of ocular pathogens such as Staphylococcus spp., coagulase-negative staphylococci, methicillin-resistant, and Haemophilus spp.) in recent decades has been a concern [9]. In 2017, a study of antibiotic susceptibility on bacteria collected from infected eyes in Bangladesh, Staphylococcus, Streptococcus, and Pseudomonas species were resistant to Gatifloxacin, Gentamicin, Tobramycin, Cloxacillin, Ciprofloxacin, Moxifloxacin, Cefixime, and Cephalexin [10]. An increase in ophthalmic antibiotic resistance may be a major problem when indicated in cataract surgery, corneal ulcers or bacterial eye infections. Raising public awareness regarding the judicious use of ophthalmic antibiotics is essential to avoid unprecedented ophthalmic epidemics and antimicrobial resistance burden. Regulations for self-medication, distribution, and selling antibiotics should include ophthalmic antibiotics. Bangladesh should initiate nationwide surveillance on antibiotic resistance in ocular microorganisms. Visualization; resources; writing – original draft; project administration: Md Nasir Ahmed. Conceptualization; writing – review and editing; supervision: Mohammed Rahmatullah. Validation; writing – review and editing: Rownak Jahan. Investigation: Chowdhury Alfi Afroze. We would like to thank the reviewers for their time and effort in reviewing the manuscript. The authors have declared no conflicts of interest. Data sharing is not applicable to this article as no new data were created or analysed in this study.
对孟加拉国眼科抗生素耐药性的关注
2022年,孟加拉国的结膜炎感染突然激增,一些医院报告的结膜炎患者数量是平时的三倍[1]。据媒体报道,自2022年7月以来,结膜炎(以眼睛发红、眼睛疼痛和刺激为特征)可能在孟加拉国急剧增加,并于9月达到高峰[2]。结膜炎的暴发报告主要发生在Chattogram、达卡、Sylhet、narayangj和Faridpur地区[3]。结膜炎在大多数情况下是由病毒感染引起的。在目前的疫情中,近一半的患者感染了人腺病毒[1]。孟加拉国在2019冠状病毒病大流行期间爆发了结膜炎,表现为红眼、瘙痒、流泪、视力下降、急性感染和炎症[4,6]。早期由肠病毒70 (ev70)引起的急性病毒性出血性结膜炎在1981年也发生过暴发[7]。病毒性感染和病毒性结膜炎不需要抗生素,除非有额外的细菌感染。然而,在目前的疫情中,莫西沙星、氯霉素等外用抗生素在没有卫生专业人员处方的情况下,由药店零售商随意配发[2]。此外,对于病毒性眼部感染,环丙沙星、地塞米松和纳他霉素也被广泛使用[8]。近几十年来,这些活动引起了人们对抗菌药物管理和眼部病原体(如葡萄球菌、凝固酶阴性葡萄球菌、耐甲氧西林和嗜血杆菌)日益增加的抗菌药物耐药性的关注[9]。2017年孟加拉国感染眼采集的细菌药敏研究发现,葡萄球菌、链球菌和假单胞菌对加替沙星、庆大霉素、妥布霉素、氯西林、环丙沙星、莫西沙星、头孢克肟和头孢氨苄耐药[10]。当白内障手术、角膜溃疡或细菌性眼部感染时,眼部抗生素耐药性的增加可能是一个主要问题。提高公众对明智使用眼科抗生素的认识对于避免前所未有的眼科流行病和抗菌素耐药性负担至关重要。自行用药、分发和销售抗生素的规定应包括眼科抗生素。孟加拉国应在全国范围内对眼部微生物的抗生素耐药性进行监测。可视化;资源;写作——原稿;项目管理:Md Nasir Ahmed。概念化;写作——审阅和编辑;监督:Mohammed Rahmatullah。验证;写作-评论和编辑:Rownak Jahan。调查:Chowdhury Alfi afreeze。我们要感谢审稿人花时间和精力审稿。作者已声明没有利益冲突。数据共享不适用于本文,因为本研究没有创建或分析新的数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信